Page last updated: 2024-10-20

pyrazinamide and Uveitis, Posterior

pyrazinamide has been researched along with Uveitis, Posterior in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Uveitis, Posterior: Inflammation of the choroid as well as the retina and vitreous body. Some form of visual disturbance is usually present. The most important characteristics of posterior uveitis are vitreous opacities, choroiditis, and chorioretinitis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Macías-Franco, S1
Fernández-García, M1
Costales-Álvarez, C1
Mayordomo-Colunga, J1
Rozas-Reyes, P1
Cordero-Coma, M1
Garzo, I1
Salazar, R1
Franco, M1
Calleja, S1
Ruiz de Morales, JM1

Other Studies

2 other studies available for pyrazinamide and Uveitis, Posterior

ArticleYear
Miliary tuberculosis and choroidal tuberculoma in a three-month old baby girl: Diagnosis and follow-up of a case.
    Archivos de la Sociedad Espanola de Oftalmologia, 2020, Volume: 95, Issue:1

    Topics: Adrenal Cortex Hormones; Amikacin; Antitubercular Agents; Choroid Diseases; Drug Therapy, Combinatio

2020
[Treatment of presumed tuberculous uveitis affecting the posterior segment: diagnostic confirmation and long term outcomes].
    Archivos de la Sociedad Espanola de Oftalmologia, 2013, Volume: 88, Issue:9

    Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Humans; Immunocompromised H

2013